Device Postmarket Surveillance Decisions Need Prior Public Input - HIMA
This article was originally published in The Gray Sheet
Executive Summary
Device postmarket surveillance criteria to be used by FDA in determining when PMS is necessary are expected to be published in a Federal Register notice in the next few weeks, agency staffers say.